Cargando…
The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
BACKGROUND: The emergence of bacterial drug resistance encourages the re-evaluation of the potential of existing antimicrobials. Lantibiotics are post-translationally modified, ribosomally synthesised antimicrobial peptides with a broad spectrum antimicrobial activity. Here, we focussed on expanding...
Autores principales: | Draper, Lorraine A, Cotter, Paul D, Hill, Colin, Ross, R Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849175/ https://www.ncbi.nlm.nih.gov/pubmed/24069959 http://dx.doi.org/10.1186/1471-2180-13-212 |
Ejemplares similares
-
Manipulation of charged residues within the two‐peptide lantibiotic lacticin 3147
por: Deegan, Lucy H., et al.
Publicado: (2010) -
Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity
por: Field, Des, et al.
Publicado: (2013) -
The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model
por: Piper, Clare, et al.
Publicado: (2012) -
Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
por: O'Connor, Eileen B, et al.
Publicado: (2007) -
Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147
por: Ryan, Aoibhín, et al.
Publicado: (2021)